Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

Recruiting

Trial locations(12 sites)

United States

Birmingham Hematology Associates, Birmingham, Alabama

PIH Health Whittier Hospital, Whittier, California

Southern Illinois Hospital Services, Carbondale, Illinois

Cancer Care Specialist of Illinois, O'Fallon, Illinois

Goshen Center for Cancer Care, Goshen, Indiana

Trinity Health, Ann Arbor, Michigan

Oncology Hematology Associates, Springfield, Missouri

Cancer Care Specialist of Reno, Reno, Nevada

Summit Medical Group, Florham Park, New Jersey

Nashville General, Nashville, Tennessee

Cancer Care Northwest, Spokane Valley, Washington

Gunderson Health, La Crosse, Wisconsin